Anti-FAM57B monoclonal antibody

Pre-made anti-FAM57B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAM57B/FAM57B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0825-Ab-1/ GM-Tg-hg-IP0825-Ab-2Anti-Human FAM57B monoclonal antibodyHuman
GM-Tg-rg-IP0825-Ab-1/ GM-Tg-rg-IP0825-Ab-2Anti-Rat FAM57B monoclonal antibodyRat
GM-Tg-mg-IP0825-Ab-1/ GM-Tg-mg-IP0825-Ab-2Anti-Mouse FAM57B monoclonal antibodyMouse
GM-Tg-cynog-IP0825-Ab-1/ GM-Tg-cynog-IP0825-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM57B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0825-Ab-1/ GM-Tg-felg-IP0825-Ab-2Anti-Feline FAM57B monoclonal antibodyFeline
GM-Tg-cang-IP0825-Ab-1/ GM-Tg-cang-IP0825-Ab-2Anti-Canine FAM57B monoclonal antibodyCanine
GM-Tg-bovg-IP0825-Ab-1/ GM-Tg-bovg-IP0825-Ab-2Anti-Bovine FAM57B monoclonal antibodyBovine
GM-Tg-equg-IP0825-Ab-1/ GM-Tg-equg-IP0825-Ab-2Anti-Equine FAM57B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0825-Ab-1/ GM-Tg-hg-IP0825-Ab-2; GM-Tg-rg-IP0825-Ab-1/ GM-Tg-rg-IP0825-Ab-2;
GM-Tg-mg-IP0825-Ab-1/ GM-Tg-mg-IP0825-Ab-2; GM-Tg-cynog-IP0825-Ab-1/ GM-Tg-cynog-IP0825-Ab-2;
GM-Tg-felg-IP0825-Ab-1/ GM-Tg-felg-IP0825-Ab-2; GM-Tg-cang-IP0825-Ab-1/ GM-Tg-cang-IP0825-Ab-2;
GM-Tg-bovg-IP0825-Ab-1/ GM-Tg-bovg-IP0825-Ab-2; GM-Tg-equg-IP0825-Ab-1/ GM-Tg-equg-IP0825-Ab-2
Products NameAnti-FAM57B monoclonal antibody
Formatmab
Target NameFAM57B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAM57B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0825-Ag-1Recombinant multi-species TLC3B/ FAM57B/ FP1188 protein


    Target information

    Target IDGM-IP0825
    Target NameFAM57B
    Gene ID83723,68952,293493,708210,489946,101100529,785988,100066097
    Gene Symbol and Synonyms1500016O10Rik,A330104J06Rik,CORD22,FAM57B,FP1188,RGD1308215,TLCD3B
    Uniprot AccessionQ71RH2
    Uniprot Entry NameTLC3B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000149926
    Target ClassificationN/A

    The target: FAM57B, gene name: FAM57B, also named as FP1188. This gene encodes a transmembrane protein, which may be a likely target of peroxisome proliferator-activated receptor gamma (PPAR-gamma). The product of the orthologous gene in mouse is related to obesity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.